MONDAY, JULY 23, 2018

Mapp Biopharmaceutical

6160 Lusk Boulevard
San Diego, CA 92121

Mapp Biopharmaceutical News

Ebola drug ZMapp gains fast-track status from the FDA

LeafBio Inc.,  the commercial arm of Mapp Biopharmaceutical Inc., recently announced that its ZMapp has gained fast-track status designation from the U.S. Food and Drug Administration (FDA) as a potential treatment for Ebola. Read More »